STOCKHOLM, Sweden, Feb. 17, 2005 (PRIMEZONE) -- Artimplant:
-- Artimplant's net sales for the full year 2004 reached SEK 4.82
millions (1.2)
-- Losses after tax amounted to SEK 42.1 millions (30.2) Adjusted
for write-down the after tax losses amounted to SEK 30.0
millions
-- The result per share amounted to SEK -1.12 (-1.21) Adjusted for
write-down the result per share amounted to SEK -0.80.
-- Global license, supply and distribution agreement for
Artimplant's Artelon(r) CMC-I Spacer* signed with Avanta
Orthopaedics.
-- Development, license and supply agreement with Biomet concerning
an implant for soft tissue repair
Forthcoming financial reports:
January-March 2005 report: May 2, 2005
January-June 2005 report: August 31, 2005
January-September 2005 report: November 10, 2005
Financial reports are available at www.artimplant.se at the same time that they're distributed to the media.
Annual general meeting
The annual general meeting of shareholders will be held at 4 p.m. on Monday, May 2, 2005 at Artimplant AB (publ), Hulda Mellgrens gata 5, Vastra Frolunda, Sweden. Registration will begin at 3:30 p.m. Shareholders who intend to participate must notify the Company no later than April 25, 2005, in one of the following ways:
-- Send an e-mail to bolagsstamma2005@artimplant.se -- Send a fax to +46 31 746 56 60 -- Phone +46 31 746 56 00 -- Write to Artimplant AB, Hulda Mellgrens gata 5, 421 32 Vastra Frolunda, Sweden.
Please include your name, personal identification number or VAT number, address, telephone number and the number of shares in the share register as per April 22, 2005. To vote at the annual general meeting, a shareholder must be entered in the share register maintained by VPC AB no later than April 22, 2005. Shareholders who have allowed their shares to be registered to a trustee, such as a bank or brokerage, must temporarily register their shares in their own name to take part in the meeting. This should be done well in advance of the date specified above.
Artimplants annual report will be published on the company's web site on April 18, and will also be available in the company headquarters. A copy of the annual report can be ordered from the company by writing to the above address.
For more information, contact: Tord Lendau, CEO, +46 31 746 5600, +46 708 369 403, tord.lendau@artimplant.se Jonas Strom, CFO, +46 31 746 5654, +46 703 016 854, jonas.strom@artimplant.se
* A schedule under "Regulatory approvals" contains a summary of all the company's approved products
This information was brought to you by Waymaker http://www.waymaker.net
The full report is available for download:
http://wpy.waymaker.net/client/waymaker1/WOLReleaseFile.aspx?id=73279&fn=wkr0001.pdf